Smick Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 27-07-2024
- Paid Up Capital ₹ 0.20 M
as on 27-07-2024
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 1.20%
(FY 2023)
- Profit 77.59%
(FY 2023)
- Ebitda 57.85%
(FY 2023)
- Net Worth 51.96%
(FY 2023)
- Total Assets -11.64%
(FY 2023)
About Smick Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Manish Jajodia, Ashish Jajodia, Ketan Shah, and One other member serve as directors at the Company.
- CIN/LLPIN
U74120MH2014PTC256879
- Company No.
256879
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Aug 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Smick Laboratories?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Jajodia  | Director | 01-Jul-2016 | Current |
| Ashish Jajodia | Director | 01-Jul-2016 | Current |
| Ketan Shah | Director | 05-Aug-2014 | Current |
| Mittal Shah | Director | 05-Aug-2014 | Current |
Financial Performance and Corporate Structure Insights of Smick Laboratories.
Smick Laboratories Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.2% increase. The company also saw a substantial improvement in profitability, with a 77.59% increase in profit. The company's net worth Soared by an impressive increase of 51.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Smick Laboratories?
In 2023, Smick Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shubham Pharmachem Pvt LtdActive 32 years 10 monthsManish Jajodia and Ashish Jajodia are mutual person
Anzen Exports Private LimitedActive 17 years 4 monthsManish Jajodia and Ashish Jajodia are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Smick Laboratories?
Unlock and access historical data on people associated with Smick Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Smick Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Smick Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
